Goodwin Procter LLP advised Inflazome on the deal. Inflazome announced its acquisition by Roche (SIX: RO, ROG; OTCQX: RHHBY) for an upfront consideration of €380 million….
This content is for Standard 1 Year members only. LoginJoin Now
Author: Paolo Bossi
…
This content is for Standard 1 Year members only. LoginJoin Now